JPMorgan Chase & Co. Begins Coverage on Tempus AI (NASDAQ:TEM)

JPMorgan Chase & Co. assumed coverage on shares of Tempus AI (NASDAQ:TEM) in a research report released on Tuesday morning, MarketBeat.com reports. The firm issued an overweight rating and a $42.00 target price on the stock.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $37.50 on Tuesday. Tempus AI has a 52-week low of $22.89 and a 52-week high of $43.88.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.